Victrex PLC (VTXPF)
OTHER OTC:VTXPF
VTXPF Stock Chart & Stats
$10.80
--
Market closed
$10.80
--
Day’s Range― - ―
52-Week Range$7.16 - $12.40
Previous CloseN/A
VolumeN/A
Average Volume (3M)180.00
Market Cap
$661.92M
Enterprise Value$525.31M
Total Cash (Recent Filing)$24.20M
Total Debt (Recent Filing)$49.00M
Price to Earnings (P/E)22.5
Beta0.34
Next Earnings
May 18, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield8.58%
Share Statistics
EPS (TTM)0.23
Shares Outstanding87,123,710
10 Day Avg. Volume0
30 Day Avg. Volume180
Financial Highlights & Ratios
PEG Ratio0.38
Price to Book (P/B)1.44
Price to Sales (P/S)2.11
P/FCF Ratio12.71
Enterprise Value/Market Cap0.79
Enterprise Value/Revenue1.79
Enterprise Value/Gross Profit4.08
Enterprise Value/Ebitda7.66
Forecast
1Y Price Target
$8.62Price Target Upside-20.20% Downside
Rating ConsensusHold
Number of Analyst Covering2
EPS Forecast (FY)<0.01
Revenue Forecast (FY)$4.05M
Bulls Say, Bears Say
Bulls Say
Low Leverage And Strong Equity PositionA debt-to-equity of 0.11 and equity ratio ~76% provide durable financial flexibility. Low leverage reduces refinancing risk, supports the dividend and capital allocation choices, and allows the company to fund restructuring or investment needs without undermining solvency over the medium term.
Strong Operating Cash Conversion And Lower CapEx121% operating cash conversion plus materially lower CapEx boosts sustainable free cash flow generation. That cash durability funds the GBP10m profit-improvement plan, supports dividends and reduces dependence on external financing, strengthening medium-term strategic optionality.
Diversified Medical Revenue MixA shift to 74% non-spine medical revenue materially reduces concentration risk in spine products. Broader medical exposure improves resilience to segment-specific cycles, increases addressable markets for value-added grades, and supports steadier long-term margin and revenue profiles.
Bears Say
Declining Revenue And Compressed MarginsNegative revenue growth and falling margins indicate structural pressure on top-line and profitability. Persistent mix, pricing or volume weakness can limit reinvestment capacity, strain returns on capital and force deeper cost actions to maintain dividends and fund strategic initiatives over the medium term.
China Facility Losses And Execution RiskAn £8m loss from the China plant highlights execution and start-up risks that can sap near-term profitability and cash. If annualization or operational issues persist, further investment or impairment may be required, delaying margin recovery and reducing the upside from local manufacturing.
Average Selling Price DeclineA 10% ASP decline is a structural headwind: even with volume gains, lower prices reduce revenue per tonne and compress gross margin. Sustained ASP pressure requires either higher-value product adoption or cost reduction to restore profitability and returns on invested capital.
Victrex News
VTXPF FAQ
What was Victrex PLC’s price range in the past 12 months?
Victrex PLC lowest stock price was $7.16 and its highest was $12.40 in the past 12 months.
What is Victrex PLC’s market cap?
Victrex PLC’s market cap is $661.92M.
When is Victrex PLC’s upcoming earnings report date?
Victrex PLC’s upcoming earnings report date is May 18, 2026 which is in 44 days.
How were Victrex PLC’s earnings last quarter?
Victrex PLC released its earnings results on Dec 02, 2025. The company reported $0.233 earnings per share for the quarter, the consensus estimate of $0.233 by $0.
Is Victrex PLC overvalued?
According to Wall Street analysts Victrex PLC’s price is currently Overvalued.
Does Victrex PLC pay dividends?
Victrex PLC pays a Semiannually dividend of $0.616 which represents an annual dividend yield of 8.58%. See more information on Victrex PLC dividends here
What is Victrex PLC’s EPS estimate?
Victrex PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Victrex PLC have?
Victrex PLC has 87,123,710 shares outstanding.
What happened to Victrex PLC’s price movement after its last earnings report?
Victrex PLC reported an EPS of $0.233 in its last earnings report, expectations of $0.233. Following the earnings report the stock price went up 7.804%.
Which hedge fund is a major shareholder of Victrex PLC?
Currently, no hedge funds are holding shares in VTXPF
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Victrex Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$8.62 (-20.20% Downside)
$8.62 (-20.20% Downside)
Blogger Sentiment
Bullish
VTXPF Sentiment 100%
Sector Average 68%
Sector Average 68%
Insider Transactions
Sold Shares
Worth £199.2K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-35.47%
12-Months-Change
Fundamentals
Return on Equity
6.40%
Trailing 12-Months
Asset Growth
-4.24%
Trailing 12-Months
Company Description
Victrex PLC
Victrex plc, through its subsidiaries, manufactures and sells polymers worldwide. The company operates through two segments, Industrial and Medical. It develops PEEK and PAEK polymer solutions, and semi-finished and finished parts. The company also offers specialist solutions for medical device manufacturers; sells thermoplastic polymer components; and engages in trading activities. It serves automotive, aerospace, energy and industrial, manufacturing and engineering, electronics, and medical markets. Victrex plc was founded in 1993 and is headquartered in Thornton-Cleveleys, the United Kingdom.
VTXPF Stock 12 Month Forecast
Average Price Target
$8.62
▼(-20.20% Downside)